Mucus plugs may trigger lung scarring in COPD patients
NCT ID NCT07236541
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether mucus plugs in the airways of COPD patients lead to lung fibrosis (scarring). Researchers will collect lung tissue and mucus from 20 people during lung cancer surgery and compare those with and without COPD. The goal is to understand the link and find new treatment targets.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could point toward new drug targets to prevent lung scarring in COPD patients.
- What could go wrong
- This is a small, early observational study with only 20 participants. It cannot prove cause and effect, and results may not apply to all COPD patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhongshan hospital
RECRUITINGShanghai, 200433, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart breathing machines at home: a new way to predict COPD crises?
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Breathing easy? new X-Ray method may spot COPD decline early
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Your Tumor's DNA might predict immunotherapy success